GulbuUzelMD

Allergy & Immunology • Springfield, VA

Clinical & Laboratory Immunology

Physician

Join to view full profile

Dr. Uzel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Uzel's full profile

Already have an account?

Office
8136 Old Keene Mill Rd
Ste A309
Springfield, VA 22152
Phone+1 800-287-2829

Fax+1 703-726-2579

Education & Training

National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1997 - 1999
Sinai Hospital of BaltimoreResidency, Pediatrics, 1994 - 1997
Ankara University FOMClass of 1991

Certifications & Licensure

MD State Medical License 2002 - 2025
VA State Medical License 2007 - 2022
IL State Medical License 2002 - 2008

Clinical Trials

Genetic Analysis of Immune Disorders Start of enrollment: 1995 Jun 06
Recruiting
Antibody Production in Immune Disorders Start of enrollment: 2002 Jun 13
Terminated
Phase 4
Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency Start of enrollment: 2023 Nov 30
Withdrawn
Phase 1, Phase 2
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): Adolescent and adult subgroup ana...
V Koneti Rao, Anna Šedivá, Virgil A S H Dalm, Alessandro Plebani, Catharina Schuetz
Clinical Immunology. 2025-01-01
Impaired development of memory B cells and antibody responses in humans and mice deficient in PD-1 signaling.
Masato Ogishi, Koji Kitaoka, Kim L Good-Jacobson, Darawan Rinchai, Baihao Zhang
Immunity. 2024-12-10
Beyond FAScinating: advances in diagnosis and management of autoimmune lymphoproliferative syndrome and activated PI3 kinase δ syndrome.
V Koneti Rao, Stefania Pittaluga, Gulbu Uzel
Hematology. American Society of Hematology. Education Program. 2024-12-06

Other

Mendelian susceptibility to mycobacterial diseases (MSMD)
Uzel G
http://www.uptodate.com/contents/mendelian-susceptibility-to-mycobacterial-diseases-msmd
UpToDate, Wolters Kluwer Health - 2012-09-19

Press Mentions

Pharming Group Announces Development Plans for Leniolisib for Additional Primary Immunodeficiencies (PIDs)December 17th, 2023